Publications
| Title | Abstract | Year(sorted ascending) Filter | PMID Filter |
|---|
| intradermal vaccination using the novel microneedle device micronjet600: past, present, and future. | intradermal immunization has become a forefront of vaccine improvement, both scientifically and commercially. newer technologies are being developed to address the need to reduce the dose required for vaccination and to improve the reliability and ease of injection, which have been major hurdles in expanding the number of approved vaccines using this route of administration. in this review, 7 y of clinical experience with a novel intradermal delivery device, the micronjet600, which is a register ... | 0 | 25745830 |
| comparative analysis of liver injury-associated cytokines in acute hepatitis a and b. | acute hepatitis a (aha) and acute hepatitis b (ahb) are caused by an acute infection of the hepatitis a virus and the hepatitis b virus, respectively. in both aha and ahb, liver injury is known to be mediated by immune cells and cytokines. in this study, we measured serum levels of various cytokines and t-cell cytotoxic proteins in patients with aha or ahb to identify liver injury-associated cytokines. | 0 | 26996565 |
| phs guideline for reducing human immunodeficiency virus, hepatitis b virus, and hepatitis c virus transmission through organ transplantation. | 0 | 23814319 | |
| the hepatitis b virus core variants that expose foreign c-terminal insertions on the outer surface of virus-like particles. | the major immunodominant region (mir) and n-terminus of the hepatitis b virus (hbv) core (hbc) protein were used to expose foreign insertions on the outer surface of hbc virus-like particles (vlps). the additions to the hbc positively charged arginine-rich c-terminal (ct) domain are usually not exposed on the vlp surface. here, we constructed a set of recombinant hbcg vectors in which ct arginine stretches were substituted by glycine residues. in contrast to natural hbc vlps and recombinant hbc ... | 0 | 26446016 |
| high persistence rate of hepatitis b virus in a hydrodynamic injection-based transfection model in c3h/hen mice. | to optimize the viral persistence rate in a hydrodynamic injection (hi) based hepatitis b virus (hbv) transfection mouse model. | 0 | 25834317 |
| solute carrier ntcp regulates innate antiviral immune responses targeting hepatitis c virus infection of hepatocytes. | chronic hepatitis b, c, and d virus (hbv, hcv, and hdv) infections are the leading causes of liver disease and cancer worldwide. recently, the solute carrier and sodium taurocholate co-transporter ntcp has been identified as a receptor for hbv and hdv. here, we uncover ntcp as a host factor regulating hcv infection. using gain- and loss-of-function studies, we show that ntcp mediates hcv infection of hepatocytes and is relevant for cell-to-cell transmission. ntcp regulates hcv infection by augme ... | 0 | 27783949 |
| hepatitis b virus lineages in mammalian hosts: potential for bidirectional cross-species transmission. | the hepatitis b virus (hbv) is a cosmopolitan infectious agent currently affecting over 350 million people worldwide, presently accounting for more than two billion infections. in addition to man, other hepatitis virus strains infect species of several mammalian families of the primates, rodentia and chiroptera orders, in addition to birds. the mounting evidence of hbv infection in african, asian and neotropical primates draws attention to the potential cross-species, zoonotic transmission of th ... | 0 | 24976704 |
| today's problems in hepatitis. | 1962 | 13947874 | |
| evidence against infectious hepatitis as a cause of cirrhosis. | 1962 | 14044608 | |
| susceptibility to serum hepatitis. effect of time and temperature upon attack rates of iceterogenic plasma and serum. | 1962 | 14012126 | |
| personal cases of post-transfusion hepatitis. | 1962 | 14022922 | |
| [transfusion hepatitis in copenhagen 1955-59]. | 1962 | 14028517 | |
| [on chromatographically demonstrable structural changes in beta-lipoproteins in serum hepatitis]. | 1962 | 14031751 | |
| [serum hepatitis after blood transfusions]. | 1962 | 14035644 | |
| [incidence of hepatitis following blood transfusion from donors with and without anamnesis of jaundice]. | 1963 | 14035645 | |
| [clinical aspects of posttransfusion hepatitis]. | 1963 | 14033148 | |
| [remarks on 4892 transfusions of blood and plasma (for the years 1961 and 1962). modern indications, results]. | 1963 | 14096709 | |
| [value of transaminase determination in donor blood in the prevention of hepatitis through transfusion]. | 1963 | 14102353 | |
| [frequency of inoculation hepatitis after plasma perfusion. statistical study based on patients treated in naval hospitals with plasma prepared by the centre de transfusion de la marine]. | 1963 | 14102498 | |
| [problems in the etiology, epidemiology and laboratory diagnosis of botkin's disease]. | 1963 | 14102612 | |
| [clinical aspects of homologous serum hepatitis, with special reference to its prognosis and preventive measures]. | 1963 | 14103575 | |
| [serum iron in epidemic hepatitis and in inoculation hepatitis]. | 1963 | 14031140 | |
| fibrinogentransmitted hepatitis. | 1963 | 14023951 | |
| [prevention of hepatitis due to transfusions]. | 1963 | 14024104 | |
| viral hepatitis. | 1963 | 14019916 | |
| the clinical use of gamma globulin. | 1963 | 13927101 | |
| a maternal death from acute hepatitis. report of a case. | 1963 | 13935637 | |
| treatment of viral hepatitis with chloroquine. | 1963 | 13941394 | |
| [hepatitis. the virus and its recognition, clinical symptoms and evaluation of liver damage]. | 1963 | 14047158 | |
| [liver disorders and results with atp]. | 1963 | 14048257 | |
| [hepatic cirrhosis, a grave complication of blood transfusions]. | 1963 | 14050905 | |
| prevention of transfusion hepatitis. | 1963 | 14051152 | |
| [complications of transfusion]. | 1963 | 14053870 | |
| hypofibrinogenemia treated without the administration of fibrinogen. | 1963 | 14056170 | |
| prevention of serum hepatitis by means of whole blood transfusion with pans no. 610 and pans-s. | 1963 | 14057150 | |
| blood transfusion hepatitis in open-heart surgery. | 1963 | 14058843 | |
| management of transfusion reactions. | 1963 | 14064854 | |
| the use of latex fixation tests in non-rheumatic states. | 1963 | 14067467 | |
| [an epidemic of inoculation hepatitis among children of a rural school and kindergarten]. | 1963 | 14069105 | |
| a physician-related outbreak of hepatitis. | 1963 | 14070730 | |
| a rapid screening test for the determination of serum glutamic oxalacetic transaminase. | 1963 | 14073440 | |
| haematology and the extracorporeal circulation. | the experience gained in the investigation of 100 cases of cardiac surgery treated by use of extracorporeal circulation has shown that certain simple laboratory tests suffice to detect induced defects in the blood and to guide therapy. these tests have been devised to detect the level of circulating heparin during perfusion; the presence of residual heparin following perfusion; the existence of a qualitative or quantitative fibrinogen deficiency; excessive fibrinolysis. any of the latter three a ... | 1963 | 14076374 |
| [complications of blood transfusions]. | 1963 | 14080035 | |
| [a few experiences in organ biopsy]. | 1963 | 14084107 | |
| studies on the serum and the infectious hepatitis viruses of man. ii. complement fixation studies with serum and infectious hepatitis viruses. | 1963 | 14084909 | |
| disease of the liver in regional enteritis. | 1963 | 14085221 | |
| viral hepatitis. | 1963 | 14089407 | |
| [complications of transfusion]. | 1963 | 14092599 | |
| [transfusions and transfusion centers]. | 1963 | 14122193 | |
| [serum enzymology of jaundice in infants]. | 1963 | 14106451 | |
| [jirgl test: its value in the differential diagnosis of jaundices]. | 1963 | 14106199 | |
| [colchicine in the treatment of viral hepatitis and encephalitis]. | 1963 | 14114232 | |
| [a study on prevention of serum hepatitis (administration of pans-s to transfused blood)]. | 1963 | 14117789 | |
| [therapy of acute and chronic hepatic diseases with the drug association, homocysteine-thiolactone, cysteine and fructose]. | 1963 | 14160823 | |
| prognosis in homologous serum hepatitis. | 1963 | 13957303 | |
| [serum iron in epidemic hepatitis and in inoculation hepatitis]. | 1963 | 13958325 | |
| surgery in acute hepatitis. causes and effects. | 1963 | 13960804 | |
| viral hepatitis. | 1963 | 13961078 | |
| [clinical contributions to the etiological mechanism of transfusion siderosis]. | 1963 | 13967737 | |
| [complications of blood transfusion]. | 1963 | 13981859 | |
| the incidence of viral hepatitis after blood transfusions. | 1963 | 13988539 | |
| [histoserological findings in viral hepatitis and cirrhosis after hepatitis]. | 1964 | 14162457 | |
| clinical significance of recent investigations of hepatitis viruses. | 1964 | 14163257 | |
| [aplastic anemia associated with serum hepatitis, hemosiderosis and glycosuria]. | 1964 | 14163644 | |
| [toxic thyroid adenoma, hemolytic antibody anemia and severe serum hepatitis. remarkable therapeutic effect of the combination of i-131, transfusions, corticoids and haloperidol]. | 1964 | 14169695 | |
| [the cortisone test in the differential diagnosis of jaundices]. | 1964 | 14170206 | |
| risk of post-transfusion viral hepatitis. | 1964 | 14171801 | |
| substitutive-inhibitory therapy in constitutional non-spherocytic erythrocytic disease. | 1964 | 14172699 | |
| [progress in the study of the hepatitis viruses]. | 1964 | 14174352 | |
| [pathology of viral hepatitis, with special reference to serum hepatitis]. | 1964 | 14174353 | |
| [epidemiology of hepatitis after blood transfusion]. | 1964 | 14174354 | |
| [clinical progress in hepatitis after blood transfusion]. | 1964 | 14174355 | |
| [non-icteric hepatitis]. | 1964 | 14174356 | |
| [prognosis of serum hepatitis]. | 1964 | 14174357 | |
| [measures for the prevention of hepatitis after blood transfusion; supervision of blood donors]. | 1964 | 14174358 | |
| [hepatitis viruses; historical considerations and problems]. | 1964 | 14174359 | |
| [measures for the prevention of hepatitis after blood transfusion, with special reference to plasma substitutes]. | 1964 | 14174360 | |
| [measures for the prevention of hepatitis after blood transfusion. treatment of preserved blood]. | 1964 | 14174361 | |
| [treatment of serum hepatitis]. | 1964 | 14174362 | |
| [viral hepatitis and blood transfusion]. | 1964 | 14174364 | |
| [the problem of serum hepatitis in japan]. | 1964 | 14175325 | |
| [pathogenesis and methods for preventing serum hepatitis]. | 1964 | 14176098 | |
| [problems relating to the isolation and antibodies of serum hepatitis viruses]. | 1964 | 14176099 | |
| complications of blood transfusion. | 1964 | 14178363 | |
| prevention and treatment of viral hepatitis. | 1964 | 14179022 | |
| complications of biliary tract surgery. | 1964 | 14180331 | |
| [recent results in the prevention of transfusion hepatitis]. | 1964 | 14181906 | |
| [on hepatitis following blood transfusion]. | 1964 | 14184067 | |
| [current status of serum hepatitis in orthopedic surgery]. | 1964 | 14184068 | |
| [hepatitis following blood transfusion with special reference to reduction of amount of blood transfused as a preventive method]. | 1964 | 14184069 | |
| [the spread of serum hepatitis]. | 1964 | 14184070 | |
| [on the pathogenesis of hepatitis]. | 1964 | 14184071 | |
| post-transfusion anicteric hepatitis. | 1964 | 14186196 | |
| selection of blood donors. | 1964 | 14186207 | |
| [studies on post-transfusion hepatitis]. | 1964 | 14187452 | |
| [recent frequent occurrence of hepatitis following blood transfusion]. | 1964 | 14196263 | |
| [liver dysfunction following chest surgery]. | 1964 | 14196264 | |
| [postoperative serum hepatitis; introduction]. | 1964 | 14196267 | |
| [serum hepatitis (statistical observations and follow-up of donors)]. | 1964 | 14196268 | |
| [liver function in post-transfusion hepatitis]. | 1964 | 14196269 |